Sign inGet started

Westlake BioPartners Fund I, L.P.

Insider CIK 1749591 · KYTX 10% owner · LTGO 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-11938,979— $00SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-11165,519— $00SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-112,066,857— $00SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-111,484,401— $00SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-113,464,072— $00SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-111,027,635— $00SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-113,547,842— $00SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-111,484,401— $04,995,328SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-113,464,072— $03,510,927SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-111,027,635— $05,944,009SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-11165,519— $05,160,847SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-112,066,857— $02,094,813SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-113,547,842— $04,916,374SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-11938,979— $01,368,532SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-11165,519— —0SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-112,066,857— —0SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-111,484,401— —0SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-113,464,072— —0SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-111,027,635— —0SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-113,547,842— —0SEC↗
LTGO Latigo Biotherapeutics, In C Conversion deriv2026-08-102026-08-11938,979— —0SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-112,066,857— —2,094,813SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-11165,519— —5,160,847SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-111,484,401— —4,995,328SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-113,464,072— —3,510,927SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-111,027,635— —5,944,009SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-113,547,842— —4,916,374SEC↗
LTGO Latigo Biotherapeutics, In C Conversion2026-08-102026-08-11938,979— —1,368,532SEC↗
KYTX Kyverna Therapeutics, Inc. P Buy2025-12-182025-12-22133,333$7.50 $1000.0K869,317SEC↗
KYTX Kyverna Therapeutics, Inc. C Conversion deriv2024-02-122024-02-144,401,771— $00SEC↗
KYTX Kyverna Therapeutics, Inc. C Conversion deriv2024-02-122024-02-143,349,538— $00SEC↗
KYTX Kyverna Therapeutics, Inc. C Conversion deriv2024-02-122024-02-144,006,624— $00SEC↗
KYTX Kyverna Therapeutics, Inc. C Conversion deriv2024-02-122024-02-148,830,901— $00SEC↗
KYTX Kyverna Therapeutics, Inc. C Conversion2024-02-122024-02-14735,984— $0735,984SEC↗
KYTX Kyverna Therapeutics, Inc. C Conversion2024-02-122024-02-143,787,940— $03,787,940SEC↗